Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 15, 2015 - Issue 11
Submit an article Journal homepage
1,482
Views
11
CrossRef citations to date
0
Altmetric
Editorials

Hypothesis: glutaminyl cyclase inhibitors decrease risks of Alzheimer’s disease and related dementias

Charles H HennekensCharles E. Schmidt College of Medicine, Florida Atlantic University, 777 Glades Road, Building 71, Suite 337, Boca Raton, FL 33431, USACorrespondence[email protected]
,
Benjamin A BensadonCharles E. Schmidt College of Medicine, Florida Atlantic University, 777 Glades Road, Building 71, Suite 337, Boca Raton, FL 33431, USA
,
Robert ZivinDepartment of Medicine, University of Miami Miller School of Medicine, Life Science Bldg 1, Room 3310F, 1600 NW 10th Ave #1140, Miami, FL 33136, USA;Translational Research & Alliance Management, Medgenics Inc., 435 Devon Park Drive, Building 700, Wayne, PA 19087, USA
&
J Michael GazianoHarvard Medical School, Division on Aging, Brigham and Women’s Hospital, 1620 Tremont Street, Boston, MA 02120, USA
Pages 1245-1248 | Published online: 08 Oct 2015

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

K. Bagri, A. Kapoor, P. Kumar & A. Kumar. (2023) Hybrid descriptors–conjoint indices: a case study on imidazole-thiourea containing glutaminyl cyclase inhibitors for design of novel anti-Alzheimer’s candidates. SAR and QSAR in Environmental Research 34:5, pages 361-381.
Read now
Ashwani Kumar, Kiran Bagri, Manisha Nimbhal & Parvin Kumar. (2021) In silico exploration of the fingerprints triggering modulation of glutaminyl cyclase inhibition for the treatment of Alzheimer’s disease using SMILES based attributes in Monte Carlo optimization. Journal of Biomolecular Structure and Dynamics 39:18, pages 7181-7193.
Read now
Judite R.M. Coimbra & Jorge A.R. Salvador. (2021) A patent review of glutaminyl cyclase inhibitors (2004–present). Expert Opinion on Therapeutic Patents 31:9, pages 809-836.
Read now

Articles from other publishers (8)

Judite R.M. Coimbra, Paula I. Moreira, Armanda E. Santos & Jorge A.R. Salvador. (2023) Therapeutic potential of glutaminyl cyclases: Current status and emerging trends. Drug Discovery Today, pages 103644.
Crossref
Carlos Elias Conti Filho, Lairane Bridi Loss, Clairton Marcolongo-Pereira, Joamyr Victor Rossoni Junior, Rafael Mazioli Barcelos, Orlando Chiarelli-Neto, Bruno Spalenza da Silva, Roberta Passamani Ambrosio, Fernanda Cristina de Abreu Quintela Castro, Sarah Fernandes Teixeira & Nathana Jamille Mezzomo. (2023) Advances in Alzheimer’s disease’s pharmacological treatment. Frontiers in Pharmacology 14.
Crossref
Nguyen Van Manh, Van-Hai Hoang, Van T.H. Ngo, Soosung Kang, Jin Ju Jeong, Hee-Jin Ha, Hee Kim, Young-Ho Kim, Jihyae Ann & Jeewoo Lee. (2022) Discovery of potent indazole-based human glutaminyl cyclase (QC) inhibitors as Anti-Alzheimer's disease agents. European Journal of Medicinal Chemistry 244, pages 114837.
Crossref
Nguyen Van Manh, Van-Hai Hoang, Van T.H. Ngo, Jihyae Ann, Tae-ho Jang, Jung-Hye Ha, Jae Young Song, Hee-Jin Ha, Hee Kim, Young-Ho Kim, Jiyoun Lee & Jeewoo Lee. (2021) Discovery of highly potent human glutaminyl cyclase (QC) inhibitors as anti-Alzheimer's agents by the combination of pharmacophore-based and structure-based design. European Journal of Medicinal Chemistry 226, pages 113819.
Crossref
Ana Xu, Feng He, Chenggong Yu, Ying Qu, Qiuqiong Zhang, Jiahui Lv, Xiangna Zhang, Yingying Ran, Chao Wei & Jingde Wu. (2019) The Development of Small Molecule Inhibitors of Glutaminyl Cyclase and Isoglutaminyl Cyclase for Alzheimer's Disease. ChemistrySelect 4:35, pages 10591-10600.
Crossref
Van-Hai Hoang, Van T. H. Ngo, Minghua Cui, Nguyen Van Manh, Phuong-Thao Tran, Jihyae Ann, Hee-Jin Ha, Hee Kim, Kwanghyun Choi, Young-Ho Kim, Hyerim Chang, Stephani Joy Y. Macalino, Jiyoun Lee, Sun Choi & Jeewoo Lee. (2019) Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimer’s Agents by Structure-Based Design. Journal of Medicinal Chemistry 62:17, pages 8011-8027.
Crossref
Hayrettin Ozan Gulcan, Açelya Mavideniz, Mustafa Fethi Sahin & Ilkay Erdogan Orhan. (2019) Benzimidazole-derived Compounds Designed for Different Targets of Alzheimer’s Disease. Current Medicinal Chemistry 26:18, pages 3260-3278.
Crossref
Manman Li, Yao Dong, Xi Yu, Yue Li, Yongdong Zou, Yizhi Zheng, Zhendan He, Zhigang Liu, Junmin Quan, Xianzhang Bu & Haiqiang Wu. (2017) Synthesis and Evaluation of Diphenyl Conjugated Imidazole Derivatives as Potential Glutaminyl Cyclase Inhibitors for Treatment of Alzheimer’s Disease. Journal of Medicinal Chemistry 60:15, pages 6664-6677.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.